The effect of a formulated honey in type 2 diabetes

The effects of a formulated honey with cinnamon, chromium and magnesium on glucose tolerance and insulin sensitivity in subjects with type 2 diabetes.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12613000624785

Acronym

nil

Enrollment

Registered

2013-05-31

Start date

2013-12-11

Completion date

2014-04-11

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to compare a formulated honey designed to deliver benefits to people with type 2 diabetes over and above the benefit of honey itself. To this end kanuka honey has been combined with cinnamon, chromium and magnesium to create a honey dietary supplement that may deliver positive effects on blood glucose and insulin levels. This formulated honey will be compared with ordinary kanuka honey firstly in an oral glucose tolerance test for acute glucose and insulin response, then over 40 days in an intervention.

Interventions

This study aims to compare a formulated honey designed to deliver benefits to people with type 2 diabetes over and above the benefit of honey itself. To this end kanuka honey has been combined with cinnamon, chromium and magnesium to create a honey dietary supplement that may deliver positive effects on blood glucose and insulin levels. 15g of honey orally is administered daily for 40 days containing 200 micrograms chromium, 120mg magnesium and 1.5g cinnamon. Adherence will be monitored by retur

This study aims to compare a formulated honey designed to deliver benefits to people with type 2 diabetes over and above the benefit of honey itself. To this end kanuka honey has been combined with cinnamon, chromium and magnesium to create a honey dietary supplement that may deliver positive effects on blood glucose and insulin levels. 15g of honey orally is administered daily for 40 days containing 200 micrograms chromium, 120mg magnesium and 1.5g cinnamon. Adherence will be monitored by returned amounts of honey at the end of 40days. There will be a 20 day washout period between treatments.

Study design

Allocation

Randomised controlled trial

Intervention model

Crossover

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

Type 2 diabetes on metformin or no oral hypoglycaemic agents

Exclusion criteria

Sulphonylurea or insulin use Medications that could affect glucose tolerance eg oral steroids HbA1c level > 80mmol/mol

Outcome results